Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gerald L. Stoner is active.

Publication


Featured researches published by Gerald L. Stoner.


Journal of General Virology | 1993

Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure

Grace S. Ault; Gerald L. Stoner

We have compared the promoter/enhancer structure of human polyomavirus JC (JCV) isolates from 11 progressive multifocal leukoencephalopathy brains. The duplications and deletions of the regulatory region were different in each patient, and usually only one sequence was found in each. The sites of strand breakage in the promoter were not random; four or five preferred sites or areas exist. Alignment of the JCV prototype Mad-1 regulatory region with the unduplicated archetypal structure defines six blocks of sequence, A to F. The preferred sites of strand breaks delineate these regions, although Mad-1 is an unusual promoter containing a break site not observed in other isolates, and an additional site is targeted in several promoters. Region A, containing the TATA box, and the first half of region C, containing several enhancer elements, and region E are consistently retained. Region B, the 23 bp insertion in the archetypal structure (relative to Mad-1) was also retained in all 11 isolates. Region D, the 66 bp insertion, was retained in isolates from three patients. Regions A and D were never duplicated, whereas regions C and E usually were duplicated or triplicated. Variation in the exact point of breakage within the preferred sites, alternative use of the sites in individual promoters and occasional short deletions at other sites result in sequences that are unique in each case. At the same time, the limited choice of break sites and the characteristic fates of the regions themselves result in three broad patterns of repeat sequences. The patterns do not correspond to the viral genotypes 1 and 2 defined by coding region base changes, and do not appear to be a stable feature of the virus. Rather, rearrangements appear to be generated in the host from a basic archetypal sequence.


Journal of Neurochemistry | 1984

Predicted Folding of β‐Structure in Myelin Basic Protein

Gerald L. Stoner

Abstract: Predictions of myelin basic protein secondary structure have not previously considered a major role for β‐structure in the organization of the native molecule because optical rotatory dispersion and circular dichroism studies have provided little, if any, evidence for β‐structure, and because a polycationic protein is generally considered to resist folding into a compact structure. However, the Chou‐Fasman, Lim, and Robson algorithms identify a total of five β‐strands in the amino acid sequence. Four of these hydrophobic amino acid sequences (37–45, 87–95, 110–118, and 150–158) could form a hairpin intermediate that initiates folding of a Greek‐key‐type β‐structure. A second fold on the more hydrophobic side, with the addition of a strand from the N‐terminus (residues 13–21), would complete the five‐stranded an‐tiparallel β‐sheet. A unique strand alignment can be predicted by phasing the hydrophobic residues. The unusual triproline sequence of myelin basic protein (100–102) is enclosed in the 14‐residue hairpin loop. If these prolines are in the trans conformation, models show that a reverse turn could occur at residues 102–105 (Pro‐Ser‐Gln‐Gly). Algorithms do not agree on the prediction of α‐helices, but each of the two large loops could accommodate an α‐helix. Myelin basic protein is known to be phosphor‐ylated in vivo on as many as five Ser/Thr residues. Phos‐phorylation might alter the dynamics of folding if the nascent polypeptide were phosphorylated in the cytoplasm. In particular, phosphorylation of Thr‐99 could neutralize cationic residues Lys‐106 and Arg‐108 within the hairpin loop. In addition, the methylation of Arg‐108 might stabilize the hairpin loop structure through hydrophobic interaction with the side chain of Pro‐97. The cationic side chains of arginine and lysine residues located on the faces of the β‐sheet (Arg‐43, Arg‐114, Lys‐13, Lys‐92, Lys‐153, and Lys‐156) could provide sites for interaction with phospholipids and other anionic structures on the surface of the myelin lipid bilayer.


Journal of General Virology | 1998

Phylogenetic analysis of 22 complete genomes of the human polyomavirus JC virus

David V. Jobes; Sylvester C. Chima; Caroline F. Ryschkewitsch; Gerald L. Stoner

The polyomavirus JC (JCV) establishes a persistent infection in the kidneys, and is the virus agent that causes the demyelinating disease progressive multifocal leukoencephalopathy. PCR and DNA sequence analyses of partial JCV genomes have shown that there are at least four main JCV types, each associated with a specific geographical region. Type 1 is of European origin, Type 2 is Asian, Type 3 is found in individuals of African decent and Type 4 is a potential recombinant of Types 1 and 3, and is widely distributed throughout the population of the United States. A comprehensive phylogenetic analysis of 22 complete JCV genomes excluding part of the regulatory region was accomplished using neighbour-joining, UPGMA and maximum parsimony methods. The resulting UPGMA and parsimony phylogenies suggest that the European Type 1 strains diverged from the other types during the evolution of JCV and that each of the other genotypes (and subtypes) falls into well-supported clades. This is the first whole genome approach to phylogeny reconstruction for JCV and represents a significant improvement over earlier studies that were limited to partial JCV sequences and the neighbour-joining method.


Archives of Virology | 1995

BK virus and a new type of JC virus excreted by HIV-1 positive patients in rural Tanzania

Hansjürgen T. Agostini; G. R. Brubaker; John F. Shao; A. Levin; Caroline F. Ryschkewitsch; W. A. Blattner; Gerald L. Stoner

SummaryHIV-1 positive patients from Tanzanian villages near Shirati were examined for urinary excretion of the human polyomaviruses JC and BK using the polymerase chain reaction (PCR). BK virus (BKV) was detected in 11 of 23 individuals tested. The BKV DNA sequences were all closely related to prototype Gardner strain and BKV (DUN). In contrast, a new type of JCV, termed Type 3 [or JCV (Shi)], was identified in seven of these same 23 individuals by comparison with Type 1 and Type 2 sequences of the VP1/intergenic/T antigen region of U.S., European and Asian strains. This suggests that JCV and BKV, although closely related, have different evolutionary histories within the African population. The six BKV regulatory regions amplified all showed the archetypal configuration. However, two of the seven JCV regulatory regions showed rearrangements: a small deletion and an inverted repeat. JCV causes a fatal demyelinating disease, progressive multifocal leukoencephalopathy (PML), in about 5% of AIDS patients in Europe and the U.S.A., but only one case has been reported in Africa. Our results suggest that this rarity of PML is not due to the absence of JCV in the African population.


The Journal of Infectious Diseases | 1997

JC Virus (JCV) Genotypes in Brain Tissue from Patients with Progressive Multifocal Leukoencephalopathy (PML) and in Urine from Controls without PML: Increased Frequency of JCV Type 2 in PML

Hansji rgen T. Agostini; Caroline F. Ryschkewitsch; Rachel Mory; Elyse J. Singer; Gerald L. Stoner

Progressive multifocal leukoencephalopathy (PML) is caused by the human polyomavirus JC (JCV), and there are at least 4 different genotypes of JCV in the United States. Type 1 strains are of European origin, whereas type 2 and 3 strains are of Asian and African origin, respectively. JCV type 4 strains are derived from a type 1/3 recombinant. In this study, the genotype distribution of JCV strains found in brain tissue or cerebrospinal fluid of 50 PML patients was compared with JCV genotypes excreted in the urine of 103 control subjects. Type determination was based on the polymerase chain reaction-amplified partial sequence of the VP1 coding gene and the noncoding region left of ori. Brain tissues from patients with PML were infected with a significantly higher proportion of JCV type 2 strains than were urine samples from the control group (P = .004). This evidence indicates a biologic difference between JCV genotypes and suggests a difference in their potential to cause PML.


Journal of General Virology | 1997

JC VIRUS REGULATORY REGION REARRANGEMENTS AND GENOTYPES IN PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY : TWO INDEPENDENT ASPECTS OF VIRUS VARIATION

Hansjürgen T. Agostini; Caroline F. Ryschkewitsch; Singer Ej; Gerald L. Stoner

JC virus (JCV) causes the central demyelinating disease progressive multifocal leukoencephalopathy (PML). JCV strains excreted in the urine are distinguishable from those in PML tissue by the configuration of their regulatory region to the right of ori: the archetypal regulatory region, 267 nucleotides long, is rearranged in PML tissue by deletion and duplication. Within the coding region JCV shows variations as a result of virus evolution. Four major genotypes are distinguishable of which Type 1 is based in Europe and Type 2 in Asia. Here, the regulatory region rearrangements and the viral genotypes of 29 JCV strains from PML brain were determined. Rearrangement patterns and genotypes were not associated. In general, deletions occurred before duplications, but exceptions to this rule exist. Each configuration of the 29 rearranged regulatory regions was unique and could be derived directly from the non-rearranged, archetypal form.


Archives of Virology | 1997

Five complete genomes of JC virus Type 3 from Africans and African Americans

Hansjürgen T. Agostini; Caroline F. Ryschkewitsch; G. R. Brubaker; John F. Shao; Gerald L. Stoner

SummaryThe central demyelinating disease progressive multifocal leukoencephalopathy (PML) is caused by the human polyomavirus JC virus (JCV). JCV evolved as geographically based genotypes of which Type 3 is an African variant first characterized in HIV-1 positive patients from Tanzania. This study reports the complete sequence of five JCV Type 3 strains. The entire JCV genome was PCR amplified from urine specimens of three African and two African-American individuals. The African consensus sequence was compared to the Type 1 and Type 2 prototype strains, JCV (Mad-1) and JCV(GS/B), respectively. Type 3 differed in 2.2% of its coding region genome from JCV (Mad-1) and in 1.3% from JCV(GS/B). Within the coding region the sequence variation among the three types was higher in the capsid protein VP1 and in the regulatory protein large T antigen than in the agnoprotein or in VP2/3. Notable Type 3-specific changes were located at sites adjacent to the zinc finger motif and near the major donor and acceptor splice junctions of large T antigen. Four of the five urinary Type 3 strains had an unrearranged, archetypal regulatory region. African strain #309 showed a 10-bp deletion at a location similar to that previously described for #307 from Tanzania. The African-American Type 3 strain #312 was closely related to the African consensus sequence. The complete genome of a urinary JCV strain from another African-American male, previously reported as a possible Type 5, showed a sequence difference of only 0.52% from the Tanzanian consensus and has been reclassified as a subtype of Type 3.


Microbes and Infection | 2000

JC virus as a marker of human migration to the Americas

Gerald L. Stoner; David V. Jobes; Mariana Fernandez Cobo; Hansjürgen T. Agostini; Sylvester C. Chima; Caroline F. Ryschkewitsch

JC virus is a ubiquitous human polyomavirus present in populations worldwide. Seven genotypes differing in DNA sequence by approximately 1-3% characterize three Old World population groups (African, European and Asian) as well as Oceania. It is possible to follow Old World populations into the New World by the JC virus genotypes they carried. The first population to settle in the Americas, the Native Americans, brought with them type 2A from northeast Asia. European settlers arriving after Columbus carried primarily type 1 and type 4. Africans brought by the slave trade carried type 3 and type 6.


Journal of Neurochemistry | 1983

Myelin‐Associated Glycoprotein: Electron Microscopic Immunocytochemical Localization in Compact Developing and Adult Central Nervous System Myelin

Henry deF. Webster; Christina G. Palkovits; Gerald L. Stoner; Jacqueline T. Favilla; Donald E. Frail; Peter E. Braun

Abstract: Light microscopic immunocytochemical studies have shown that myelin‐associated glycoprotein (MAG) is localized in myelin of the developing CNS; but in the adult, MAG appears to be restricted to periaxonal regions of myelinated fibers. To extend these observations, we embedded optic nerves of 15‐day‐old rats, adult rats, and an adult human in epon after aldehyde and osmium tetroxide fixation. After 5% H2O2 pretreatment, thin sections were immunostained with 1:250–1:5,000 rabbit antiserum to rat CNS MAG according to the avidin‐biotin‐peroxidase complex (ABC) method. Dense deposits of reaction product covered compact myelin in both developing and adult optic nerves. When we used 1:500, 1:1,000, and 1:2,000 anti‐MAG, less intense immunostaining of myelin was found. We also obtained the same localization in compact myelin with the peroxidaseantiperoxidase (PAP) method. With 1:250 anti‐MAG, dense deposits of reaction product were not observed on axolemmal membranes or on oligodendroglial membranes located periaxonally and paranodally. In thin sections of adult human optic nerve, anti‐MAG also stained compact myelin intensely. When thin sections of rat and human optic nerves were treated with preimmune or absorbed serum, no immunostaining was observed. Immunoblot tests showed that our MAG antisera did not react with any non‐MAG myelin proteins. In contrast with earlier light microscopic data, this study shows that MAG localization does not change during CNS development; both developing and adult compact myelin sheaths contain MAG. As many biochemical studies also show that MAG is present in compact myelin, we suggest that this 100,000 dalton glycoprotein now be called myelin glycoprotein (MGP) instead of MAG.


Archives of Virology | 2001

New JC virus (JCV) genotypes from Papua New Guinea and Micronesia (type 8 and type 2E) and evolutionary analysis of 32 complete JCV genomes

David V. Jobes; Jonathan S. Friedlaender; Charles S. Mgone; Hansjürgen T. Agostini; George Koki; Richard Yanagihara; T. C. N. Ng; Sylvester C. Chima; Caroline F. Ryschkewitsch; Gerald L. Stoner

Summary. The JC virus (JCV) is a ubiquitous human polyomavirus that frequently resides in the kidneys of healthy individuals and is excreted in the urine of a large percentage of the population. Geographic-specific JCV variants, isolated from urine and from brain of progressive multifocal leukoencephalopathy (PML) patients, have been grouped into seven distinct genotypes based on whole genome analysis and by individual polymorphic nucleotides (typing sites) in the VP1 coding region. Mutations in the archetypal regulatory region, sometimes consisting of deletions and/or duplications, are also useful taxonomic characters for further characterizing and subdividing genotypes. Investigation of JCV variation in Papua New Guinea (PNG) revealed three distinct variants called PNG-1, PNG-2, and PNG-3. These variants exhibited consistent coding region and regulatory region mutations. Evolutionary analysis of 32 complete JCV genomes including six new viral genomes from the western Pacific suggests that the new PNG JCV variants are closely associated with the broad group of Type 2 strains of JCV found throughout Asia, forming a monophyletic group with the Northeast Asian strains (Type 2A). Within the Type 2 clade, however, the PNG JCV variants cluster as two distinct groups and are therefore described here as new JCV genotypes designated Type 2E and Type 8.

Collaboration


Dive into the Gerald L. Stoner's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David V. Jobes

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Duard L. Walker

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

Henry deF. Webster

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Dov Soffer

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Richard Yanagihara

University of Hawaii at Manoa

View shared research outputs
Top Co-Authors

Avatar

Sylvester C. Chima

University of KwaZulu-Natal

View shared research outputs
Top Co-Authors

Avatar

Christopher L. Cubitt

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Grace S. Ault

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge